Status: Recruiting
Itraconazole Therapy In Bronchiectasis With Airway Mold
The primary objective of this study is to evaluate the feasibility of itraconazole therapy in patients with bronchiectasis and airway mold. Feasibility will be assessed through recruitment success, treatment adherence, tolerability, and participant retention. The study will also explore the impact on respiratory symptoms and airway microbiome diversity.
Participants needed: 30
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: May 29, 2026Locations: 1
Eligibility criteria
Age ≥18 years seen at Mycobacterial and Bronchiectasis Clinic (MMBC) in Rocheste... [+4]
Known diagnosis of allergic bronchopulmonary aspergillosis or invasive fungal di... [+7]